CLIO Cosmetics Co.,Ltd

KOSDAQ:A237880 Rapport sur les actions

Capitalisation boursière : ₩558.2b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

CLIO CosmeticsLtd Croissance future

Future contrôle des critères 2/6

CLIO CosmeticsLtd devrait augmenter ses bénéfices et son chiffre d'affaires de 16.8% et de 13.5% par an respectivement. Le BPA devrait croître de de 16.2% par an. Le rendement des capitaux propres devrait être 17.1% dans 3 ans.

Informations clés

16.8%

Taux de croissance des bénéfices

16.2%

Taux de croissance du BPA

Personal Products croissance des bénéfices29.3%
Taux de croissance des recettes13.5%
Rendement futur des capitaux propres17.1%
Couverture par les analystes

Good

Dernière mise à jour09 Aug 2024

Mises à jour récentes de la croissance future

Recent updates

If EPS Growth Is Important To You, CLIO CosmeticsLtd (KOSDAQ:237880) Presents An Opportunity

Jun 26
If EPS Growth Is Important To You, CLIO CosmeticsLtd (KOSDAQ:237880) Presents An Opportunity

What CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) 27% Share Price Gain Is Not Telling You

May 25
What CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) 27% Share Price Gain Is Not Telling You

The Strong Earnings Posted By CLIO CosmeticsLtd (KOSDAQ:237880) Are A Good Indication Of The Strength Of The Business

May 21
The Strong Earnings Posted By CLIO CosmeticsLtd (KOSDAQ:237880) Are A Good Indication Of The Strength Of The Business

We Like These Underlying Return On Capital Trends At CLIO CosmeticsLtd (KOSDAQ:237880)

Apr 24
We Like These Underlying Return On Capital Trends At CLIO CosmeticsLtd (KOSDAQ:237880)

Some Shareholders Feeling Restless Over CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) P/E Ratio

Apr 01
Some Shareholders Feeling Restless Over CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) P/E Ratio

Is CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) 1.0% Dividend Worth Your Time?

Apr 13
Is CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) 1.0% Dividend Worth Your Time?

When Should You Buy CLIO Cosmetics Co.,Ltd (KOSDAQ:237880)?

Mar 30
When Should You Buy CLIO Cosmetics Co.,Ltd (KOSDAQ:237880)?

Here's Why CLIO CosmeticsLtd (KOSDAQ:237880) Can Manage Its Debt Responsibly

Mar 16
Here's Why CLIO CosmeticsLtd (KOSDAQ:237880) Can Manage Its Debt Responsibly

Does This Valuation Of CLIO Cosmetics Co.,Ltd (KOSDAQ:237880) Imply Investors Are Overpaying?

Mar 02
Does This Valuation Of CLIO Cosmetics Co.,Ltd (KOSDAQ:237880) Imply Investors Are Overpaying?

CLIO CosmeticsLtd's (KOSDAQ:237880) Shareholders Are Down 47% On Their Shares

Feb 17
CLIO CosmeticsLtd's (KOSDAQ:237880) Shareholders Are Down 47% On Their Shares

Does CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) Weak Fundamentals Mean That The Market Could Correct Its Share Price?

Feb 02
Does CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) Weak Fundamentals Mean That The Market Could Correct Its Share Price?

What Type Of Shareholders Make Up CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) Share Registry?

Jan 18
What Type Of Shareholders Make Up CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) Share Registry?

Are Dividend Investors Making A Mistake With CLIO Cosmetics Co.,Ltd (KOSDAQ:237880)?

Jan 05
Are Dividend Investors Making A Mistake With CLIO Cosmetics Co.,Ltd (KOSDAQ:237880)?

Should You Think About Buying CLIO Cosmetics Co.,Ltd (KOSDAQ:237880) Now?

Dec 23
Should You Think About Buying CLIO Cosmetics Co.,Ltd (KOSDAQ:237880) Now?

Are CLIO CosmeticsLtd's (KOSDAQ:237880) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Dec 08
Are CLIO CosmeticsLtd's (KOSDAQ:237880) Statutory Earnings A Good Reflection Of Its Earnings Potential?

CLIO CosmeticsLtd (KOSDAQ:237880) Seems To Use Debt Rather Sparingly

Nov 25
CLIO CosmeticsLtd (KOSDAQ:237880) Seems To Use Debt Rather Sparingly

Prévisions de croissance des bénéfices et des revenus

KOSDAQ:A237880 - Estimations futures des analystes et données financières antérieures (KRW Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/2026504,51751,81753,00060,5006
12/31/2025455,77845,35641,05050,1439
12/31/2024396,60039,18335,42546,4675
3/31/2024348,48932,16044,48045,288N/A
12/31/2023330,58427,69634,85635,725N/A
9/30/2023313,26424,21228,84929,842N/A
6/30/2023296,39417,55628,77329,877N/A
3/31/2023281,58815,03621,33022,356N/A
12/31/2022272,45510,129-1,41728,205N/A
9/30/2022259,4885,3094,23336,732N/A
6/30/2022250,9039,67335932,940N/A
3/31/2022240,7677,81515,09747,579N/A
12/31/2021232,7449,26748,29851,952N/A
9/30/2021223,55510,19537,28838,046N/A
6/30/2021214,7855,89337,63038,588N/A
3/31/2021208,3667,95011,85712,987N/A
12/31/2020218,2169,58510,52411,877N/A
9/30/2020237,5054,63014,45418,066N/A
6/30/2020249,1217,43614,09219,257N/A
3/31/2020260,3375,64347,15354,508N/A
12/31/2019250,3832,94228,02239,819N/A
9/30/2019230,1275,48259,24173,667N/A
6/30/2019214,24851750,47366,775N/A
3/31/2019199,73411922,54539,491N/A
12/31/2018187,37899648,26862,214N/A
9/30/2018186,9561,538-8,8171,843N/A
6/30/2018187,4424,151-2,6575,524N/A
3/31/2018181,8515,625-6,0461,336N/A
12/31/2017193,6807,933N/A-22,989N/A
9/30/2017197,94313,777N/A-4,928N/A
6/30/2017201,32415,634N/A-1,244N/A
3/31/2017205,10716,339N/A-132N/A
12/31/2016193,59020,812N/A4,757N/A
9/30/2016177,60225,362N/A22,878N/A
6/30/2016164,51027,612N/A33,408N/A
3/31/2016136,41025,537N/A43,975N/A
12/31/2015107,07717,694N/A39,820N/A
12/31/201442,493608N/A-833N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de A237880 ( 16.8% par an) est supérieure au taux d'épargne ( 2.6% ).

Bénéfices vs marché: Les bénéfices de A237880 ( 16.8% par an) devraient croître plus lentement que le marché KR ( 28.3% par an).

Croissance élevée des bénéfices: Les bénéfices de A237880 devraient augmenter, mais pas de manière significative.

Chiffre d'affaires vs marché: Le chiffre d'affaires de A237880 ( 13.5% par an) devrait croître plus rapidement que le marché KR ( 10.6% par an).

Croissance élevée des revenus: Le chiffre d'affaires de A237880 ( 13.5% par an) devrait croître plus lentement que 20% par an.


Prévisions de croissance du bénéfice par action


Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de A237880 devrait être faible dans 3 ans ( 17.1 %).


Découvrir les entreprises en croissance